1. Home
  2. CTOR

CTOR

CITIUS ONCOLOGY INC

as 12-18-2024 9:35am EST

$
-
.
-
-
+
$
-
.
-
-
+
-
.
-
-
%

Stocks

NYSE

Citius Oncology Inc is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products targeting unmet needs with a focus on oncology products. In addition, Citius completed enrollment in its Phase 2b trial of CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids.

Founded: 2021 Country:
United States
United States
Employees: N/A City: NEW YORK
Market Cap: 89.9M IPO Year: N/A
Target Price: $4.50 AVG Volume (30 days): 5.7M
Analyst Decision: Strong Buy Number of Analysts: 2
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.29 EPS Growth: N/A
52 Week Low/High: $0.85 - $49.00 Next Earning Date: 12-24-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: